Journal profile · Biochemistry, Genetics and Molecular Biology-Molecular Medicine
Frontiers in Genetics
ISSN 1664-8021 · Frontiers Media S.A. · UNITED STATES
Frontiers in Genetics: CAS Zone 3 · Biology (2025 upgraded edition); impact factor 2.97; fully open access; APC charged, amount not published; median 61 days to acceptance (126 articles, last 24 months); 968 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Frontiers in Genetics is published by Frontiers Media S.A. and is in Zone 3 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cancer-related molecular mechanisms research, RNA modifications and cancer and Ferroptosis and cancer prognosis, together about 27.8% of its articles. Its main subfields are Molecular Biology and Genetics. (generated from OpenAlex topic counts and CAS ranking data)
Frontiers in Genetics publishes research on genes and genomes relating to all the domains of life, from humans to livestock, and plants to other model organisms. Led by Field Chief Editor Enrico Domenici (Department of Cellular, Computational and Integrated Biology, University of Trento, Italy) Frontiers in Genetics is indexed in PubMed Central (PMC) and Scopus, among others, and explores the full spectrum of genetic and genomic research, encompassing fundamental studies and their clinical applications, while also embracing methodological advancements and exploring their applications and implications. Topics of interest include, but are not limited to: • how genes or genomes relate to traits and human pathophysiology • advances in genomic data technology and analysis • gene flow among species and populations • livestock genome research Interactions between organisms, their environment, and xenobiotics • molecular and cellular genetics • societal implications of genetic research. Submissions that emphasize advancement in the understanding of the function and variability of the genome, the use of genetic and genomic tools, and the analysis of the genetic underpinnings of biological processes are of particular interest to this journal. Furthermore, the journal actively welcomes submissions which support and advance the UN’s Sustainable Development Goals (SDGs), notably SDG 3: good health and well-being. Manuscripts that focus solely on clinical outcomes, patient management, or therapeutic interventions without a clear genetic or genomic component are not suitable for publication in this journal. Studies that are purely epidemiological or observational, without a foundation in genetic or genomic mechanisms, are also not within the scope of this journal. Manuscripts consisting solely of bioinformatics, computational analyses of public data which are not accompanied by validation (independent clinical or patient cohort, or biological validation in vitro or in vivo) or are not highly innovative are not suitable for publication in this journal. Please refer to the Frontiers Standards for research methodology policy, for more information. Frontiers in Genetics is committed to advancing developments in the field of genetics and genomics by allowing unrestricted access to articles, and communicating scientific knowledge to both researchers and the public, to enable the scientific breakthroughs of the future. Frontiers in Genetics is a member of the Committee on Publi
From the journal's Aims & Scope
Research area (LetPub): Biochemistry, Genetics and Molecular Biology-Molecular Medicine
Editorial board by country: none in mainland China; most named United States 7, Italy 4, United Kingdom 2, Spain 2, Switzerland 1 (17 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology11.5%
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology9.3%
- Ferroptosis and cancer prognosisMedicine7%
- Genetic and phenotypic traits in livestockBiochemistry, Genetics and Molecular Biology5.7%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology5.7%
- Epigenetics and DNA MethylationBiochemistry, Genetics and Molecular Biology5.3%
- Genetic Mapping and Diversity in Plants and AnimalsBiochemistry, Genetics and Molecular Biology5.1%
- Bioinformatics and Genomic NetworksBiochemistry, Genetics and Molecular Biology4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Genetics & Heredity | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Genetics & Heredity | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Genetics & Heredity | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePMCEmbasePublisher website
Other: EBSCO, ProQuest, Dimensions, CNKI, CLOCKSS, Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.97LetPub ·
- Impact factor (publisher)
- 3Publisher website ·
- CiteScore 2026-06
- 6.9LetPub ·
- CiteScore (publisher)
- 6.9Publisher website ·
- SJR 2026-06
- 0.83LetPub ·
- SNIP 2026-06
- 0.81LetPub ·
- h-index
- 61LetPub ·
- h-index
- 180OpenAlex ·
- i10-index
- 9,017OpenAlex ·
- 2-year mean citedness
- 2.96OpenAlex ·
- Self-citation rate
- 3.3%LetPub ·
- Share of gold OA articles
- 99.94%LetPub ·
Volume
- Articles per year
- 879LetPub ·
Articles by year OpenAlex count · 17,231 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 696 | 696 | 240 |
| 2025 | 968 | 968 | 2,019 |
| 2024 | 1,144 | 1,144 | 6,052 |
| 2023 | 1,879 | 1,879 | 17,995 |
| 2022 | 3,833 | 3,833 | 50,951 |
| 2021 | 2,775 | 2,775 | 54,265 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
61 daysMedian, submission to acceptance · P25–P75 44 days – 108 days
- Acceptance to online
- median 26 days (126 articles)
- Submission to online
- median 91 days
- Sample
- 126 articles with submission and acceptance dates (1,832 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 14 weeksLetPub ·
- Submission to publication (journal-reported)
- about 14 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | CHF 3,150 | Yes | CC BY | |
| OpenAlex | CHF 3,150 | — | — | |
| LetPub | USD 3,295 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Keywords
- 5–8
- Reference style
- Harvard
- Templates
- LaTeX and Word
Policy excerpts from the journal's websiteAI use, Conflicts of interest, License & copyright, Open access, Peer review
- AI use Use of AI to create written or visual content
Authors should not list a generative AI technology as a co-author or author of any submitted manuscript. Generative AI technologies cannot be held accountable for all aspects of a manuscript and consequently do not meet the criteria required for authorship. If the author of a submitted manuscript has used written or visual content produced by or edited using a generative AI technology, this use mu…
Source ↗Publisher website ·- Conflicts of interest Safeguards against financial conflicts of interest
Only leading researchers acting as Associate Editors, who are not part of Frontiers' staff, can make acceptance decisions based on reviews performed by external experts acting as Community Reviewers or Reviewers. None have a financial incentive to accept articles, i.e. they are not paid for their role as Associate Editor or community Reviewer, and any award scheme is not linked to acceptances of m…
Source ↗Publisher website ·- License & copyright Open access and copyright
Upon submission, authors grant Frontiers a license to publish, display, store, copy, and reuse the content. Model summary
All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…
Source ↗Publisher website ·- Open access Open access and copyright
Articles are published open access under CC-BY version 4.0; authors retain copyright, and content is free to download, distribute, and adapt with appropriate attribution. Model summary
All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…
Source ↗Publisher website ·- Peer review Peer review
Frontiers applies the CrossMark logo to maintain published content and alert readers to changes. Model summary
Our rigorous, transparent peer review process combines expert review and constructive dialogue to strengthen your manuscript.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Frontiers Media S.A.
- Country or region
- UNITED STATES
- Language
- English
- ISSN
- 1664-8021
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Frontiers in Genetics
What CAS zone is Frontiers in Genetics in?
In the 2025 upgraded edition of the CAS Journal Ranking, Frontiers in Genetics is in Zone 3 of Biology, and in Zone 3 of the minor category Genetics & Heredity. In the 2026 Xinrui edition it is in Zone 3 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Frontiers in Genetics?
The latest impact factor listed by LetPub is 2.97; CiteScore 6.9, h-index 180.
How long does peer review take at Frontiers in Genetics?
Based on the dates recorded on 126 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 61 days (interquartile range 44–108 days); authors report an average review time of about 14 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Frontiers in Genetics?
According to the journal's author guidelines: Keywords: 5–8; Reference style: Harvard; Templates: LaTeX and Word. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Frontiers in Genetics based?
Of the 17 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (7), Italy (4) and United Kingdom (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Frontiers in Genetics?
According to LetPub and DOAJ records, Frontiers in Genetics is indexed in SCIE, Scopus and DOAJ. The journal's website also lists Web of Science, PMC and Embase; that list has not been checked against each database.
Is Frontiers in Genetics open access, and what is the APC?
Frontiers in Genetics is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .